• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Bipartisan Federal Legislation to Address Insulin Access and Affordability.两党联合提出的解决胰岛素可及性和可负担性问题的联邦立法。
Diabetes Spectr. 2021 Nov;34(4):394-398. doi: 10.2337/ds21-0008. Epub 2021 Jun 30.
2
Past experiences with surprise medical bills drive issue knowledge, concern and attitudes toward federal policy intervention.以往对意外医疗账单的经历会影响人们对联邦政策干预的了解、关注和态度。
Health Econ Policy Law. 2022 Jul;17(3):298-331. doi: 10.1017/S1744133121000281. Epub 2021 Oct 21.
3
Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications.从胰岛素中吸取的教训:制定负担得起的糖尿病和肥胖症药物的政策处方。
Diabetes Care. 2024 Aug 1;47(8):1246-1256. doi: 10.2337/dci23-0042.
4
Insulin insulated: barriers to competition and affordability in the United States insulin market.胰岛素绝缘:美国胰岛素市场竞争与可负担性的障碍
J Law Biosci. 2020 Oct 9;7(1):lsaa061. doi: 10.1093/jlb/lsaa061. eCollection 2020 Jan-Dec.
5
A State of Uncertainty: An Analysis of Recent State Legislative Proposals to Regulate Preventive Services in the United States.一种不确定状态:对美国近期规范预防服务的州立法提案的分析
Inquiry. 2019 Jan-Dec;56:46958019841514. doi: 10.1177/0046958019841514.
6
How substance use prevention research gets used in United States federal policy.物质使用预防研究如何在美国联邦政策中得到应用。
Addiction. 2022 Aug;117(8):2235-2241. doi: 10.1111/add.15874. Epub 2022 Apr 1.
7
Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.不到三分之一的医院提供符合要求的全膝关节置换术价格透明度信息。
Clin Orthop Relat Res. 2022 Dec 1;480(12):2316-2326. doi: 10.1097/CORR.0000000000002288. Epub 2022 Jun 24.
8
What predicts legislative success of early care and education policies?: Applications of machine learning and Natural Language Processing in a cross-state early childhood policy analysis.什么因素预示着早期儿童保育和教育政策的立法成功?:机器学习和自然语言处理在跨州幼儿政策分析中的应用。
PLoS One. 2021 Feb 11;16(2):e0246730. doi: 10.1371/journal.pone.0246730. eCollection 2021.
9
A Drug Pricing "Transparency" Bill With Strong Bipartisan Support But Would It Accomplish Much?一项获得两党大力支持的药品定价“透明度”法案,但它能有多大成效呢?
P T. 2019 Jun;44(6):323.
10
Assessing US Pharmaceutical Policy and Pricing Reform Legislation in Light of European Price and Cost Control Strategies.评估美国药品政策和定价改革立法,借鉴欧洲价格和成本控制策略。
J Health Polit Policy Law. 2022 Dec 1;47(6):755-778. doi: 10.1215/03616878-10041163.

引用本文的文献

1
Can nutrition interventions tackle the global insulin affordability via improving diabetes management and reducing insulin demand?营养干预能否通过改善糖尿病管理和减少胰岛素需求来解决全球胰岛素可负担性问题?
Glob Health Res Policy. 2022 May 11;7(1):13. doi: 10.1186/s41256-022-00247-1.

本文引用的文献

1
Out-of-Pocket Spending for Insulin, Diabetes-Related Supplies, and Other Health Care Services Among Privately Insured US Patients With Type 1 Diabetes.美国 1 型糖尿病私人保险患者的胰岛素、糖尿病相关用品和其他医疗保健服务的自付费用。
JAMA Intern Med. 2020 Jul 1;180(7):1012-1014. doi: 10.1001/jamainternmed.2020.1308.
2
Interchangeable Insulins - New Pathways for Safe, Effective, Affordable Diabetes Therapy.可互换胰岛素——安全、有效、可负担得起的糖尿病治疗新途径。
N Engl J Med. 2020 Mar 12;382(11):981-983. doi: 10.1056/NEJMp1916387.
3
Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018.2007-2018 年美国品牌药物的目录价格、净价格和折扣变化。
JAMA. 2020 Mar 3;323(9):854-862. doi: 10.1001/jama.2020.1012.
4
Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299-1311.勘误。胰岛素可及性与可负担性工作组:结论与建议。《糖尿病护理》2018年;41卷;1299 - 1311页。
Diabetes Care. 2018 Aug;41(8):1831. doi: 10.2337/dc18-er08. Epub 2018 Jun 28.
5
Why Are We Failing to Address the Issue of Access to Insulin? A National and Global Perspective.为什么我们未能解决胰岛素获取问题?国家和全球视角。
Diabetes Care. 2018 Jun;41(6):1125-1131. doi: 10.2337/dc17-2123.
6
Pharmacy Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing.药品福利管理公司、品牌药价格与患者费用分担
Ann Intern Med. 2018 Mar 20;168(6):436-437. doi: 10.7326/M17-2506. Epub 2018 Feb 13.
7
Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending.医疗保险D部分处方药价格回扣与患者自付费用及联邦支出的关联
JAMA Intern Med. 2017 Aug 1;177(8):1185-1188. doi: 10.1001/jamainternmed.2017.1885.

两党联合提出的解决胰岛素可及性和可负担性问题的联邦立法。

Bipartisan Federal Legislation to Address Insulin Access and Affordability.

作者信息

Socal Mariana P, Bai Ge

机构信息

Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Johns Hopkins Carey Business School, Baltimore, MD.

出版信息

Diabetes Spectr. 2021 Nov;34(4):394-398. doi: 10.2337/ds21-0008. Epub 2021 Jun 30.

DOI:10.2337/ds21-0008
PMID:34866873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8603115/
Abstract

Insulin access and affordability affect the well-being of millions of Americans. In the 116th Congress (2019-2020), seven bipartisan bills were introduced to address this issue. In this article, the authors group the seven bills into five categories (enhancing price transparency, limiting cost-sharing, changing biosimilar regulations, certifying prices, and permitting importation), summarize the main content of these bills, and discuss their implications. Understanding the bipartisan insulin pricing policy proposals can facilitate the development of a feasible legislative agenda to improve insulin access and affordability.

摘要

胰岛素的可及性和可负担性影响着数百万美国人的福祉。在第116届国会(2019 - 2020年)期间,共提出了七项两党法案来解决这一问题。在本文中,作者将这七项法案分为五类(提高价格透明度、限制费用分担、改变生物类似药监管规定、认证价格以及允许进口),总结了这些法案的主要内容,并讨论了它们的影响。了解两党胰岛素定价政策提案有助于制定可行的立法议程,以改善胰岛素的可及性和可负担性。